The Patent Finder

Terms ending in 2038

BGI Shenzhen

Every in-force patent on BGI Shenzhen's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,121,549Application of Alistipes shahii in preparing a composition for preventing and/or treating lipid metabolism related diseases
In force
 · High confidence
BGI ShenzhenIn forceHigh confidence
US 11,788,138Nucleic Acid Sequencing Using Affinity Reagents
In force
 · High confidence
Mgi Tech Co., Ltd.In forceHigh confidence
US 11,376,289Composition and uses thereof
In force
 · High confidence
BGI ShenzhenIn forceHigh confidence
US 10,851,410Nucleic Acid Sequencing Using Affinity Reagents
In force
 · High confidence
Mgi Tech Co., Ltd.In forceHigh confidence
US 12,104,203Method for Constructing Library of Cell-Free DNAs in Body Fluids and Application Thereof
In force
 · High confidence
BGI ShenzhenIn forceHigh confidence
5 of 5 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by BGI Shenzhen.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited